Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2019

Feb 6, 2019

29745_dirs_2019-02-05_a55fa5ee-6eeb-40a9-a9ff-1cba8c635fae.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2019-02-01

Reporting Person: Ricks David A (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-01 Common Stock M 12222 Acquired 131708 Direct
2019-02-01 Common Stock F 5485 $119.86 Disposed 126223 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-01 Restricted Stock Unit $ M 12222 Disposed 2019-02-01 Common Stock (12222.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6124 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.